High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib

Brain metastases (BMs) and bone metastases seriously affect the prognosis of lung cancer patients. How to optimize the use of existing targeted drugs is an important way to address the clinical needs of the central nervous system in the individualized treatment of non-small cell lung cancer (NSCLC)....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhang Ying, Zhang Xiaowen, Wang Fang, Feng Yan, Tang Huaping
Format: article
Langue:EN
Publié: De Gruyter 2021
Sujets:
R
Accès en ligne:https://doaj.org/article/b6e0ac2177964adead41d36295725fc0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!